Multi-Omics Integration Reveals a Competitive Endogenous RNAs Network for the Identification of Progression Biomarkers and the Stratification of Patients Diagnosed With Nephroblastoma

Abstract

Specific types of nephroblastoma (Wilms' tumor, WT) are known to associate with poor overall survival. Emerging experimental evidence has demonstrated that competitive endogenous RNA (ceRNA) networks have important roles in regulating cancer occurrence, but the roles of ceRNAs in regulating the WT progression and the patient outcomes remain unclear. Using the multi-omics data of 132 WT patients collected from TARGET database, an integration analysis pipeline was performed to construct a highly reliable ceRNA network. As results, a total of 147 nodes (116 mRNAs, 15 miRNAs, and 16 lncRNAs) were identified and used to explore the underlying mechanism for WT progression. WGCNA analysis further identified several prognostic molecules, including hsa-mir-93, LINC00087 and RP5-1086K13, that significantly associated with the overall survival rate. And, enrichment analysis verified the participation of these molecules in tumor-related pathways, such as those controlling autophagy and cadherin-mediated adhesion. Importantly, the WT patients were classified into three categories according to the ceRNA network, which significantly correlated with the overall survival. In conclusion, the ceRNA network could be a promising tool to further validate the prognostic biomarkers and categories of patients diagnosed with WT.

Downregulation of LNMAS orchestrates partial EMT and immune escape from macrophage phagocytosis to promote lymph node metastasis of cervical cancer

“…Five lncRNAs were consistently dysregulated in both datasets (Fig. 1B ), including ENSG00000238133, ENSG00000224079, ENSG00000249307 and ENSG00000224950, which were reported to correlate with human cancer progression [ 20 – 23 ]. Additionally, ENSG00000232415, termed LNMAS here, was significantly downregulated in the LNpos group, as determined by qPCR (Fig.…”

Molecular interactions between metformin and D-limonene inhibit proliferation and promote apoptosis in breast and liver cancer cells

“…More importantly, the novel potential pharmacological effects of metformin and D -limonene were illustrated. Also, among these targets, the inducible nitric oxide synthase ( iNOS ) or type II genes correlated with carcinogenic processes in liver and breast cancers play a central role in inflammation and expresses protective effects against detrimental damage [ 37 ].…”

The Emerging Landscape of Long Non-Coding RNAs in Wilms Tumor

“…Liu et al combined expression data and survival analysis to identify two lncRNAs (HNF1A-AS1 and DELU2) that were significantly related to the overall survival time of WT patients, and may be used as novel prognostic markers for WT ( 46 ). Furthermore, Wang et al found that LINC00087 was significantly related to the overall survival rate of WT patients, and may become a prognostic biomarker of WT ( 113 ).…”